Targeted Alpha Therapy with 212Pb-NNV003 for the Treatment of CD37 Positive B-Cell Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL)

Amal Saidi(Orano (France)), Jostein Dahle(Oslo University Hospital), Astri Fjelde Maaland(University of Oslo), Julien Torgue(Orano (France)), Helèn Heyerdahl(Nordic Nanovector (Norway))
Blood
November 29, 2018
Cited by 5


Related Papers